Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Paul Conyngham
Person

Paul Conyngham

Tracked across 1 events · 9 articles · First seen Mar 15, 2026 · Last active Mar 16, 2026

Sentiment
70
Attention
4
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Tech
AI-Designed mRNA Vaccine Shrinks Dog's Cancer
Paul Conyngham, a data engineer, spearheaded the development of the personalized mRNA cancer vaccine for his dog Rosie using AI tools like ChatGPT and Google DeepMind===AlphaFold. His innovative approach has garnered significant attention in the scientific community, potentially paving the way for new cancer treatments.
Mar 15, 2026 · 9 articles
Relationships (4)
Core Intelligence Technologies co-founder ↔ Paul Conyngham Paul Conyngham is a co-founder of Core Intelligence Technologies.
Google DeepMind===AlphaFold ↔ Paul Conyngham Unknown
University of Queensland collaborator ↔ Paul Conyngham Paul Conyngham collaborated with University of Queensland for vaccine administra
University of New South Wales collaborator ↔ Paul Conyngham Paul Conyngham collaborated with UNSW researchers on genomic sequencing and vacc
NEWSDESK
Track Paul Conyngham live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.